Hilde Rosing
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 214 publications
Transfer of trastuzumab and pertuzumab into human breast milk: a case report.
Journal: Cancer chemotherapy and pharmacology
Published: February 11, 2026
An Overview of Liquid Chromatography-Mass Spectrometry (LC-MS) Methods for the Quantification of Antibody-Drug Conjugates.
Journal: Biomedical chromatography : BMC
Published: August 25, 2025
Reducing the Burden of Interaction Studies in Cancer Patients Using a Stable Isotopically Labeled Microtracer: A Proof-of-Concept Study with Alectinib.
Journal: Clinical pharmacology and therapeutics
Published: July 21, 2025
Validated LC-MS/MS Method for Quantifying the Antiparasitic Nitroimidazole DNDI-0690 in Preclinical Target Site PK/PD Studies.
Journal: Biomedical chromatography : BMC
Published: March 06, 2025
Quantitative analysis of DNDI-6174 using UPLC-MS/MS: A preclinical target site pharmacokinetic study.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: March 05, 2025
Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors.
Journal: Oncology and therapy
Published: February 05, 2025
Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels: the Alpe2U study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 04, 2025
Advancing Therapeutic Drug Monitoring for Oral Targeted Anticancer Drugs: From Hospital-Based Towards Home-Sampling.
Journal: Biomedical chromatography : BMC
Published: December 11, 2024
An ultra-sensitive liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 2H6-alectinib and alectinib in human plasma to support a microtracer food-effect trial.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: December 05, 2024
Stabilization of Abiraterone in Human Plasma Using the Esterase Inhibitor Bis(4-nitrophenyl) Phosphate.
Journal: Therapeutic drug monitoring
Published: November 18, 2024
LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib.
Journal: Journal of pharmaceutical and biomedical analysis
Published: November 08, 2024
Last Updated: 09/26/2026